| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82317c98745e29636e6af1c724ed9586 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-413
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-262 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-14 |
| filingDate |
2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_854ed934fcd23e5416470f88e71847a8 |
| publicationDate |
2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110073495-A |
| titleOfInvention |
Compositions and Methods for Making Stable Monolayer Liposome Suspensions |
| abstract |
Described are compositions and methods for making and using stable transparent to translucent monolayer liposome suspensions. The suspension comprises a liposome formulation having a plurality of uniform monolayer liposome particles having an average particle size of about 50 nm to about 290 nm. The particles have a density from about 0.95 g / cc to about 1.25 g / cc and are suspended in the outer phase composition present in an amount from about 30% to about 75% by weight of the liposome suspension. Liposomal formulations are formed from aqueous liposome solutions comprising an oil soluble composition and a water soluble composition. The oil-soluble composition is present at a concentration of about 5% to about 33% by weight of the liposome solution, and the water-soluble composition is present at a concentration of about 67% to about 95% by weight of the liposome solution. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185492-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612559-B2 |
| priorityDate |
2008-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |